Investment Objective
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in The Health Care Select Sector Index.
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Latest XLV News
Performance
| 1 month | +2.41% | | 3 years | +21.76% |
| 3 months | +12.89% | | 5 years | +11.19% |
| 1 year | +37.95% | | Since inception | +6.44% |
Quote Details
| Previous close | $48.76 |
| Open day’s range | 48.79 – 49.36 |
| Net asset value (NAV) | 48.78 (05/20/2013) |
| Daily volume | 8,294,917 |
| Average volume (3 months) | 7,658,360 |
Data as of 4:00pm ET, 05/21/2013
Peer Comparisonvs. Health ETFs
| | XLV | Category |
|---|
| Performance 5-yr return | +11.19% | +13.03% |
| Expense Gross exp ratio | 0.18% | 0.47% |
| Risk 5 year sharpe ratio | 0.71 | 0.75 |
| Net assets | $8.0B | $776.1M |
| Average market cap | $60.3B | $19.4B |
| Average P/E | 19.7 | 21.6 |
| Dividend / Share | -- | 0.22% |
Competitors
| VHT Vanguard Health Care ETF |
| IXJ iShares S&P Global Healthcare Index Fund |
| IYH iShares Dow Jones US Healthcare Sector I... |
Holdings
Top 5 Sectors
Portfolio weighting
Top 10 Holdings
Portfolio weighting
| JNJ Johnson & Johnson | 13.06% |
| PFE Pfizer Inc | 11.45% |
| MRK Merck & Co Inc | 7.79% |
| AMGN Amgen Inc | 4.27% |
| GILD Gilead Sciences Inc | 4.23% |
| ABBV AbbVie Inc | 3.99% |
| BMY Bristol-Myers Squibb Company | 3.58% |
| UNH UnitedHealth Group Inc | 3.39% |
| LLY Eli Lilly and Company | 3.03% |
| BIIB Biogen Idec Inc | 2.90% |
+0.53 / +1.09%
-0.01 / -0.02%
.
